4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000018
Chief Medical Officer sold 2,657 shares at $23.59 ($62,679)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Geffner Michael Chief Medical Officer | 2025-01-22 | Sale | −2,657 | $23.59 | $62,679 | 132,314 | D |
| Open-market sales · 2,657 sh · avg $23.59 · $62,679 | |||||||
Loading xslF345X05/wk-form4_1737753717.xml…